Beclometasone/formoterol/glycopyrronium
From Infogalactic: the planetary knowledge core
| Combination of | |
|---|---|
| Beclometasone dipropionate | Glucocorticoid |
| Formoterol | Long-acting β2 agonist |
| Glycopyrronium bromide | Antimuscarinic |
| Clinical data | |
| Trade names | Trimbow |
| Routes of administration |
Inhalation |
| Identifiers | |
| ATC code | R03AL09 (WHO) (not yet official) |
Beclometasone/formoterol/glycopyrronium (trade name Trimbow) is an inhalable combination drug for the treatment of chronic obstructive pulmonary disease (COPD). In May 2017, the European Committee for Medicinal Products for Human Use recommended granting a marketing authorisation for the drug.[1]
References
- ↑ Lua error in package.lua at line 80: module 'strict' not found.
<templatestyles src="Asbox/styles.css"></templatestyles>
 |
This drug article relating to the respiratory system is a stub. You can help Wikipedia by expanding it. |
Categories:
- Drugs that are a combination of chemicals
- Chemical articles without CAS Registry Number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Bronchodilators
- Combination drugs
- Respiratory system drug stubs
